Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. May 29, 2018. Elizabeth Zybczynski.

Executive Summary

Baxter Healthcare's Elizabeth Zybczynski – who once worked in the aerospace and defense industries – was excited when she learned her firm was taking part in a US FDA pilot program to measure the capability and maturity of medical device manufacturing sites using the Capability Maturity Model Integration (CMMI) appraisal approach. See what she said about it here.

"I've been in the medical device space and pharmaceutical space for about 15 years. But before that, I was in the aerospace and defense industries. And CMMI – well, it grew up in those industries. CMMI has been in those industries for nearly 30 years now, so I know the model and I know what it can do for those industries to elevate quality – and I knew it would work well in the medical device industry." –Elizabeth Zybczynski, global director of production and process control, Baxter Healthcare

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT122730

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel